Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 26;8(1):10.
doi: 10.1186/s40348-021-00119-7.

A fresh look to the phenotype in mono-allelic likely pathogenic variants of the leptin and the leptin receptor gene

Affiliations
Review

A fresh look to the phenotype in mono-allelic likely pathogenic variants of the leptin and the leptin receptor gene

Ingrid Koerber-Rosso et al. Mol Cell Pediatr. .

Abstract

Leptin (LEP) and leptin receptor (LEPR) play a major role in energy homeostasis, metabolism, and reproductive function. While effects of biallelic likely pathogenic variants (-/-) on the phenotype are well characterized, effects of mono-allelic likely pathogenic variants (wt/-) in the LEP and LEPR gene on the phenotype compared to wild-type homozygosity (wt/wt) have not been systematically investigated. We identified in our systematic review 44 animal studies (15 on Lep, 29 on Lepr) and 39 studies in humans reporting on 130 mono-allelic likely pathogenic variant carriers with 20 distinct LEP variants and 108 heterozygous mono-allelic likely pathogenic variant carriers with 35 distinct LEPR variants. We found indications for a higher weight status in carriers of mono-allelic likely pathogenic variant in the leptin and in the leptin receptor gene compared to wt/wt, in both animal and human studies. In addition, animal studies showed higher body fat percentage in Lep and Lepr wt/- vs wt/wt. Animal studies provided indications for lower leptin levels in Lep wt/- vs. wt/wt and indications for higher leptin levels in Lepr wt/- vs wt/wt. Data on leptin levels in human studies was limited. Evidence for an impaired metabolism in mono-allelic likely pathogenic variants of the leptin and in leptin receptor gene was not conclusive (animal and human studies). Mono-allelic likely pathogenic variants in the leptin and in leptin receptor gene have phenotypic effects disposing to increased body weight and fat accumulation.

Keywords: Animal; Humans; LEP; LEPR; Phenotype.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart of the included studies reporting phenotype in animals as well as in humans with mono-allelic likely pathogenic variant A in the LEP and B in the LEPR gene
Fig. 2
Fig. 2
A, B Illustration of individual BMI z scores in A children and B adults depending on LEP genotype (wt/wt vs. wt/- vs. -/-). A Children: LEP wt/wt (n = 2): mean: 0.5 (range 0.4–0.6); LEP wt/- (n = 8): mean − 0.1 (range − 2.4–1.3); LEP-/- (n = 25): mean 5.5 (range 2.7 − 12.5); B Adults: LEP wt/wt (n = 4): mean 0.3 (range − 1.0–1.0); LEP wt/- (n = 64): mean 1.0 (range − 0.9–4.2); LEP-/- (n = 13): mean 4.8 (range 4.1–5.2); C BMI z scores in association with LEP variant (green circle: wt/wt subject; blue square: wt/- subject; red triangle: -/- subject; yellow line: BMI z score = 1) (subjects reported in different studies, but showing the same variant are grouped together. It is not distinguished between children and adults. Only variants reported to be carried by wt/- are shown. However, not always a BMI z score for the wt/- carrier could be calculated; *p < 0.05)
Fig. 3
Fig. 3
Illustration of individual body fat (BF) values [%] for children and adults in association with genotype for LEP (A, B) or LEPR (C, D) (wt/wt vs. wt/- vs. -/-; *p < 0.05). A Children: LEP wt/wt (n = 3): mean 17% (range 14–20%); LEP wt/- (n = 2): mean 19% (range 15–23%); LEP-/- (n = 6): mean 53% (range 50–57%). B Adults: LEP wt/wt (n = 0) LEP wt/- (n = 11): mean 28% (range 15–36%); LEP-/- (n = 2): mean 50.4% (range 42.8–57.9%); C Children: LEPR wt/wt (n = 7) mean 31% (range 18–49%); LEPR wt/- (n = 2): mean 20.5% (range 20–21%); LEPR-/- (n = 13): mean 54% (range 41–68%); D Adults: LEPR wt/wt (n = 7) mean 38% (range 20–52%); LEPR wt/- (n = 22) mean: 35% (range 18–48%); LEPR-/- (n = 7): mean 57% (range 50.7–66%)
Fig. 4
Fig. 4
Leptin levels [ng/ml] in relation to BMI z score in LEP (A) and LEPR (B) variant carriers and wildtype subjects (wt/wt vs. wt/- vs. -/-). Data are shown for children and adults
Fig. 5
Fig. 5
A, B Illustration of individual BMI z scores in children (A) and adults (B) depending on LEPR genotype (wt/wt vs. wt/- vs. wt/-; *p ≤ 0.05). A Children: LEPR wt/wt (n = 13): mean 0.5 (range 0.4–0.6); LEPR wt/- (n = 7): mean 0.9 (range − 1.6–2.4); LEPR-/- (n = 17): mean 5.7 (range 3.3–10.6); B Adults: LEPR wt/wt (n = 10): mean 2.5 (range 0.4–5.0); LEPR wt/- (n = 60): mean 1.2 (range − 1.0–3.8); LEPR-/- (n = 30): mean 4.5 (range 0.4–6.1); C BMI z scores in association with LEPR variant (green circle: wt/wt subject; blue square: wt/- subject; red triangle: -/- subject; unfilled red triangle: compound wt/- subject) (Only variants reported to be carried by wt/- are shown). However, not always a BMI z score for the wt/- carrier could be calculated. It is not distinguished between children and adults. Subjects reported in different studies, but showing the same variant are grouped together. If wt/wt subjects in one family with two different wt/- variants were described, they BMI z scores were plotted for both variants)

Similar articles

Cited by

References

    1. Friedman J. 20 years of leptin: leptin at 20: an overview. J Endocrinol. 2014;223(1):T1–8. doi: 10.1530/JOE-14-0405. - DOI - PubMed
    1. Oswal A, Yeo GS. The leptin melanocortin pathway and the control of body weight: lessons from human and murine genetics. Obes Rev. 2007;8(4):293–306. doi: 10.1111/j.1467-789X.2007.00378.x. - DOI - PubMed
    1. Farooqi IS, O'Rahilly S. 20 years of leptin: human disorders of leptin action. J Endocrinol. 2014;223(1):T63–70. doi: 10.1530/JOE-14-0480. - DOI - PubMed
    1. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered. 1950;41(12):317–318. doi: 10.1093/oxfordjournals.jhered.a106073. - DOI - PubMed
    1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432. doi: 10.1038/372425a0. - DOI - PubMed

LinkOut - more resources